AquaVage, Fat Grafting for Butts, Breasts and Beyond...

Share Article

Aquavage, a unique new fat grafting device has now been cleared by the FDA. It is designed for high volume autologous fat collection for buttock and breast augmentation, and full body sculpting utilizing the patient's own fat. The AquaVage will be released in October at the upcoming ASPS conference in Seattle, WA.

LipiSystems Inc. announced today clearance by the FDA of their new highly anticipated AquaVage fat grafting system. According to company president Mel Kimsey, "AquaVage is the first high volume fat grafting device that meets the needs of the surgeon performing high volume autologous fat transfer". The advantage of AquaVage is a closed, sterile, disposable, no fuss system that works every time. It does not clog, even in very fibrous tissue and maintains high fat cell viability that is required for successful fat graft retention and stem cell retrieval. It is fast, simple and safe, saving the surgeon considerable time in the OR.

According to the American Society of Plastic Surgery, more than 46,000 fat transfer procedures were performed in 2008. During autologous fat transfer, fat cells are transferred from one area of the body to another. As an alternative to cosmetic dermal fillers, fat transfer is becoming a popular procedure to fill in wrinkles, fine lines or other depressions in the skin caused by surgery, aging, acne or trauma. Fat transfer can also be used to refine, enhance and contour the face, lips, buttocks and breasts. Since fat transfer uses your body's own tissues, the body does not reject the cells. The result of fat transfer surgery is a soft and natural look.

Beyond that a virtual tsunami of interest has developed around stem cells derived from adipose tissue or fat. The stem cells can be used for breast and buttock augmentation, regenerating heart tissue in heart attack patients, rebuilding vascular tissue, treating canine arthritis and the list goes on. Studies are being conducted in all these areas by numerous universities and research groups. It is felt by many physicians that stem cell therapy will revolutionize the way medicine is practiced today putting tools in the hands of the physician to actually heal rather than just treat symptoms. According to one physician, "Fat is a ready source of stem cells and there is plenty of it".

The AquaVage is scheduled for market release at the upcoming American Society of Plastic Surgery annual meeting in Seattle, Washington in October. For further information please visit


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Debbie Jordan
Visit website